Peritoneal Mesothelioma

Peritoneal Mesothelioma: Understanding a Rare but Serious Cancer

Peritoneal mesothelioma is a rare and aggressive cancer that develops in the peritoneum, the thin membrane lining the abdominal cavity and covering most abdominal organs. 

While mesothelioma is often associated with the lungs (pleural mesothelioma), the peritoneal form accounts for roughly 10–20% of all mesothelioma cases.

Despite its seriousness, advances in treatment have significantly improved outcomes in recent years. This article explores what peritoneal mesothelioma is, its causes, symptoms, diagnosis, treatment options, and prognosis.

What Is Peritoneal Mesothelioma?

Peritoneal mesothelioma forms in the abdominal lining after malignant cells begin growing uncontrollably. The peritoneum plays an essential role in protecting and supporting abdominal organs such as the stomach, liver, and intestines. When cancer develops here, it can interfere with digestion, fluid balance, and overall abdominal function.

Unlike many other cancers, peritoneal mesothelioma is strongly linked to a single primary cause: asbestos exposure.

Causes and Risk Factors

1. Asbestos Exposure

The overwhelming majority of peritoneal mesothelioma cases are linked to asbestos fibers. When inhaled or swallowed, microscopic asbestos fibers can travel through the body and become lodged in the abdominal lining. Over time—often decades—these fibers cause inflammation, scarring, and eventually cancerous changes.

2. Occupational Risk

People most at risk include those who worked in:

Construction

Shipbuilding

Industrial manufacturing

Insulation installation

Automotive brake repair

Family members of workers may also be at risk due to secondhand exposure from asbestos fibers carried home on clothing.

3. Latency Period

One of the most challenging aspects of this disease is its long latency period. Symptoms often appear 20 to 50 years after exposure, making early detection difficult.

Symptoms of Peritoneal Mesothelioma

Early symptoms are often vague and may resemble common digestive issues. As the disease progresses, symptoms become more pronounced.

Common symptoms include:

Abdominal pain or swelling

Bloating or feeling of fullness

Unexplained weight loss

Nausea and vomiting

Changes in bowel habits

Fatigue

Fluid buildup in the abdomen (ascites)

Because these symptoms overlap with many other conditions, diagnosis is frequently delayed.

How Is It Diagnosed?

Diagnosing peritoneal mesothelioma involves multiple steps:

Medical History and Physical Examination

Doctors assess exposure history and examine abdominal swelling or tenderness.

Imaging Tests

CT scans

MRI scans

PET scans

Biopsy

A tissue sample is required to confirm the diagnosis. This may be done through minimally invasive surgery (laparoscopy).

Pathology Testing

Specialized testing identifies whether the cancer cells are mesothelioma and determines the specific cell type.

Early and accurate diagnosis is crucial for determining treatment eligibility.

Treatment Options

Treatment depends on the stage of the cancer, overall health, and whether the disease has spread.

1. Cytoreductive Surgery (CRS)

This procedure removes visible tumors from the abdominal cavity. It is often combined with heated chemotherapy.

2. HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

HIPEC involves circulating heated chemotherapy drugs directly in the abdominal cavity during surgery. This approach targets microscopic cancer cells while limiting systemic side effects.

3. Systemic Chemotherapy

For patients who are not candidates for surgery, intravenous chemotherapy may be used to slow disease progression.

4. Emerging Therapies

Immunotherapy

Targeted therapy

Clinical trials

In recent years, the combination of CRS and HIPEC has significantly improved survival rates for eligible patients.

Prognosis and Survival Rates

Peritoneal mesothelioma once carried a very poor prognosis. However, modern treatments have improved outcomes substantially.

Patients who undergo CRS + HIPEC may achieve median survival rates of 3 to 5 years or longer.

Some patients experience long-term remission.

Prognosis depends on tumor type, stage, overall health, and response to treatment.

Early detection and treatment at specialized centers greatly improve survival chances.

Living with Peritoneal Mesothelioma

A diagnosis of peritoneal mesothelioma can be overwhelming. Patients often benefit from:

Multidisciplinary cancer care teams

Nutritional support

Pain management specialists

Emotional and psychological counseling

Support groups for patients and families

Legal options may also be available for individuals exposed to asbestos in occupational settings.

Prevention and Awareness

The only proven way to prevent peritoneal mesothelioma is to avoid asbestos exposure. Many countries have banned or strictly regulated asbestos use, but it still exists in older buildings and materials.

If you suspect past asbestos exposure, inform your healthcare provider—especially if experiencing persistent abdominal symptoms.

Final Thoughts

Peritoneal mesothelioma is a rare but serious cancer closely tied to asbestos exposure. Although it can be difficult to detect early, advances in surgical techniques and targeted therapies have significantly improved survival outcomes.

Raising awareness about symptoms and occupational risks remains critical. With earlier diagnosis and specialized treatment, patients today have more hope than ever before.

If you or a loved one may have been exposed to asbestos and are experiencing unexplained abdominal symptoms, consult a healthcare professional promptly for evaluation.